(:ESRX)
Business Focus: N/A
Oct 25, 2022 09:15 am ET
Express Scripts Announces Strategic Partnership with Centene to Unlock Greater Prescription Drug Savings
Express Scripts to manage pharmacy benefits for approximately 20 million Centene members
May 31, 2021 04:45 pm ET
Skylight Health Group Reports Record First Quarter 2021 Financial Results
Skylight Health Group Inc. (TSXV:SHG; OTCQX: SHGFF) (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States, today announced its financial results for the first quarter ended March 31, 2021. First...
May 16, 2019 06:00 am ET
Express Scripts Simplifies Digital Health Technology Marketplace for Consumers and Payers
ST. LOUIS, May 16, 2019 /PRNewswire/ -- To make it simpler for consumers and payers to navigate the hundreds of thousands of currently available personal health technologies and interventions, Express Scripts, a Cigna company, will introduce the industry's first, stand-alone digital health formulary.
Apr 16, 2019 02:00 pm ET
Accredo, a Full-Service Specialty Pharmacy, Expands Best-in-Class Services with New Pharmacy in Hawaii
ST. LOUIS, April 16, 2019 /PRNewswire/ -- Express Scripts today announced that its specialty pharmacy, Accredo, will open a new location in Honolulu to provide high-touch pharmacy care to people living with chronic, complex health conditions, such as multiple sclerosis, cancer and hemophilia. Scheduled to open in summer 2019, the new pharmacy will offer a range of services, including walk-in consultations with a pharmacist, home delivery via courier and mail, and a site-of-care (or ambulatory) infusion center with onsite nurses. Oncology treatments and intravenous immunoglobulin will be amon
Dec 19, 2018 04:51 pm ET
Celanese Set to Join S&P 500
NEW YORK, Dec. 19, 2018 /PRNewswire/ -- Celanese Corp. (NYSE: CE) will replace Express Scripts Holding Co. (NASD: ESRX) in the S&P 500 effective prior to the open of trading on Monday, December 24. S&P 500 constituent Cigna Corp. (NYSE:CI) is acquiring Express Scripts Holding in a deal expected to close soon pending final conditions. Post-merger, Cigna will change its Global Industry Classification Standard (GICS) Sub-Industry group to Health Care Services from Managed Health Care.
Dec 12, 2018 07:00 am ET
Walmart and Express Scripts Sign Three-Year Agreement to Deliver Greater Value to Insured and Uninsured Pharmacy Customers
BENTONVILLE, Ark. and ST. LOUIS, Dec. 12, 2018 /PRNewswire/ -- Today, Walmart and Express Scripts (NASDAQ: ESRX) announced an extension to the companies' existing network agreement to provide access to Walmart's prescription services for Express Scripts clients' covered members. The companies also made a commitment to deliver additional affordable prescription solutions to millions of underinsured and uninsured Americans.
Dec 06, 2018 06:30 am ET
Express Scripts Names Dr. Dorian Lo as President of Express Scripts Canada; Michael Biskey to retire in First Quarter 2019
MISSISSAUGA, ON, Dec. 6, 2018 /CNW/ - Express Scripts Holding Company (NASDAQ: ESRX) today announced Michael Biskey will retire as President, Express Scripts Canada in first quarter 2019. Dr. Dorian Lo, a Canadian physician and highly accomplished senior executive, has been named as Mr. Biskey's successor. Mr. Biskey and Dr. Lo will work together to ensure a smooth leadership transition. Mr. Biskey led the transformation of Express Scripts Canada from a claims adjudicator to the leading Canadian Pharmacy Benefit Management company, leveraging its adjudication platform to introduce new, inn
Nov 27, 2018 08:55 am ET
New Research Coverage Highlights Immunomedics, Surmodics, PDF Solutions, Stepan, Express Scripts Holding, and BioCryst Pharmaceuticals — Consolidated Revenues, Company Growth, and Expectations for 201
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Immunomedics, Inc. (NASDAQ:IMMU), Surmodics, Inc. (NASDAQ:SRDX), PDF...
Nov 19, 2018 05:00 am ET
Petco and Express Scripts Team Up to Revolutionize Home Delivery of Pet Medicines
SAN DIEGO and ST. LOUIS, Nov. 19, 2018 /PRNewswire/ -- Petco and Express Scripts (NASDAQ: ESRX), a healthcare company focused on delivering personalized solutions to improve healthcare, today announced a new strategic alliance that will enable millions of pet parents to order and receive pet medicines from the comfort and convenience of home.
Nov 13, 2018 06:01 am ET
Express Scripts Introduces Novel Formulary Built for Evolution of Drug Pricing
ST. LOUIS, Nov. 13, 2018 /PRNewswire/ -- As drug pricing strategies continue to evolve, Express Scripts (NASDAQ: ESRX) is keeping clients ahead of the game. Today, the company announced it is introducing a novel formulary to provide employers and health plans a better opportunity to leverage changing dynamics to help lower their members' out-of-pocket costs. The Express Scripts' National Preferred Flex Formulary, available January 1, 2019, provides a way for plans to cover lower list price products, such as new authorized alternatives that drug makers are bringing to the market, and reduce
Nov 06, 2018 03:03 pm ET
Express Scripts' myMatrixx Launches myDataSense Analytics Tool
ST. LOUIS and TAMPA, Fla., Nov. 6, 2018 /PRNewswire/ -- myMatrixx®, a leader in pharmacy services for workers' compensation programs and a subsidiary of Express Scripts Holding Company (NASDAQ: ESRX), announces the release of myDataSenseSM, an innovative and customizable digital analytics tool that will help drive patient safety and savings.
Oct 31, 2018 04:11 pm ET
Express Scripts Announces 2018 Third Quarter Results
ST. LOUIS, Oct. 31, 2018 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced consolidated 2018 third quarter net income of $1,071.6 million or $1.89 per diluted share. Consolidated 2018 third quarter adjusted earnings per diluted share were $2.43, which represents growth of 28% over consolidated 2017 third quarter adjusted earnings per diluted share./1
Oct 24, 2018 06:00 am ET
Express Scripts' Innovative Advanced Opioid Management Solution Shifts First-Time Opioid Users to Safer, Short-Term Prescriptions
ST. LOUIS, Oct. 24, 2018 /PRNewswire/ -- As President Trump signs bipartisan legislation to help improve our nation's response to the opioid abuse epidemic, Express Scripts (NASDAQ: ESRX) released new data today showing a dramatic shift in first-time opioid users enrolled in its Advanced Opioid ManagementSM solution being prescribed safer, short-term prescriptions of 7 days or less. Short-term opioid prescriptions can significantly reduce the risk of a patient misusing or abusing a medication. The new opioid law supports Express Scripts' ongoing efforts by strengthening our ability to work c
Oct 23, 2018 08:03 am ET
National Drug Purchasing Coalition - member companies include PepsiCo, Inc. and ExxonMobil - and Express Scripts Team Up to Create New Pharmacy Benefit Design for Greater Performance Accountability, T
ST. LOUIS, Oct. 23, 2018 /PRNewswire/ -- The National Drug Purchasing Coalition (NDPC), an employer-led coalition, is announcing the Total Performance ManagementSM solution for its members: a transformative new way for employers to provide pharmacy benefits that guarantees pricing transparency, alignment on outcomes, and accountability for performance. Express Scripts (NASDAQ: ESRX), the nation's leading pharmacy benefit manager, worked closely with the NDPC to develop the innovative solution. NDPC member companies include PepsiCo, Inc.; ExxonMobil; Chevron Corporation; Sodexo; Yum! Brands,
Oct 17, 2018 09:00 am ET
Express Scripts Offers New Value-Based Program for Migraine
ST. LOUIS, Oct. 17, 2018 /PRNewswire/ -- Migraine headaches are a painful reality for 39 million Americans. Severe migraine pain sends someone in the U.S. to an emergency room every 10 seconds, contributes to 113 million work days lost every year, costs employers $13 billion in lost productivity, and leads to billions of dollars spent in outpatient visits, emergency room visits and hospitalizations[i].
Oct 16, 2018 04:13 pm ET
Express Scripts Holding Company Announces Third Quarter 2018 Earnings Release Details
ST. LOUIS, Oct. 16, 2018 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) ("Express Scripts") announced today its intention to release its 2018 third quarter financial results on Wednesday, October 31, 2018, after the market closes. Management will not be holding a conference call to review results.
Oct 09, 2018 05:13 pm ET
Express Scripts Readies Emergency Support for Impacted Members in Advance of Hurricane Michael
ST. LOUIS, Oct. 9, 2018 /PRNewswire/ -- In advance of the expected landfall later this week of Hurricane Michael, Express Scripts reminds patients to include their prescription medications in their emergency plans by printing their medication history, securing vital prescription drugs, and ensuring adequate medication supplies.
Oct 09, 2018 02:29 pm ET
Express Scripts Readies Emergency Support for Impacted Members in Advance of Hurricane Michael
ST. LOUIS, Oct. 9, 2018 /PRNewswire/ -- In advance of the expected landfall later this week of Hurricane Michael, Express Scripts reminds patients to include their prescription medications in their emergency plans by printing their medication history, securing vital prescription drugs, and ensuring adequate medication supplies.
Oct 09, 2018 08:45 am ET
Express Scripts Introduces Medicare Part D Plan Offerings for 2019
ST. LOUIS, Oct. 9, 2018 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) today introduced its Express Scripts Medicare® Prescription Drug Plan (PDP) offerings for 2019, offering seniors three high-value options for coverage and savings.
Oct 05, 2018 05:33 pm ET
Akcea Announces Its Access and Distribution Strategy for TEGSEDI™ (inotersen)
Akcea Therapeutics, Inc. (NASDAQ: AKCA), an affiliate of Ionis Pharmaceuticals, Inc.(NASDAQ: IONS), announced today that they are working together with Accredo® specialty pharmacy, a subsidiary of Express Scripts (NASDAQ: ESRX), to distribute...
Oct 03, 2018 08:08 am ET
Express Scripts Flattens the Trajectory of the Diabetes Epidemic with SafeGuardRx Diabetes Care Value® Program
ST. LOUIS, Oct. 3, 2018 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) released new data today showing significantly improved clinical outcomes and reduced drug spending for diabetes -- one of America's deadliest and most costly health conditions.
Oct 01, 2018 08:08 am ET
Inside Rx Announces Access to Fertility Services for Uninsured Americans with Freedom FP Fertility Pharmacy
FRANKLIN LAKES, N.J., Oct. 1, 2018 /PRNewswire/ -- Inside Rx, LLC, a partially owned subsidiary of Express Scripts (NASDAQ:ESRX) that provides discounted medications for uninsured and underinsured Americans, today announced it is collaborating with Freedom FP Fertility Pharmacy to promote more affordable access to fertility treatments and specialized care.
Sep 28, 2018 08:20 am ET
New Research Coverage Highlights Employers, Alliqua BioMedical, Express Scripts Holding, CF Industries, Nutanix, and Coca-Cola — Consolidated Revenues, Company Growth, and Expectations for 2018
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Employers Holdings Inc (NYSE:EIG), Alliqua BioMedical, Inc. (NASDAQ:ALQA),...
Sep 19, 2018 03:00 pm ET
Express Scripts Earns Highest Overall Customer Satisfaction Rating According to Independent Survey of Plan Sponsors
ST. LOUIS, Sept. 19, 2018 /PRNewswire/ -- According to the Pharmacy Benefit Management Institute's (PBMI) 2018 PBM Customer Satisfaction Report of plan sponsors, Express Scripts leads the industry in customer satisfaction, earning the highest overall satisfaction rating, 8.1, among large PBMs serving more than 20 million members.
Sep 12, 2018 02:19 pm ET
Express Scripts Implements Emergency Procedures for Affected Members in Advance of Hurricane Florence
ST. LOUIS, Sept. 12, 2018 /PRNewswire/ -- In advance of the expected landfall later this week of Hurricane Florence, Express Scripts reminds patients to include their prescription medications in their emergency plans by printing their medication history, securing vital prescription drugs, and ensuring adequate medication supplies.
Sep 05, 2018 09:00 am ET
Inside Rx® Prescription Savings Card Boosts Deep Discounts on Brand-Name Medications to more than 130 Drugs
FRANKLIN LAKES, N.J., Sept. 5, 2018 /PRNewswire/ -- Inside Rx, LLC, a partially owned subsidiary of Express Scripts (NASDAQ:ESRX), today announced it added 14 new medications to its brand medications listing for the Inside Rx® prescription savings card. The program now offers deep discounts to over 130 brand-name drugs to patients who are uninsured or underinsured and pay the retail price for their medications. The new brand products may offer more affordable access to cancer and nasal polyps therapies and expand access to anti-fungal, COPD, acne, asthma, heart health, infections, and topica
Aug 24, 2018 10:53 am ET
Express Scripts Stockholders Approve Acquisition by Cigna
ST. LOUIS, Aug. 24, 2018 /PRNewswire/ -- Stockholders of Express Scripts Holding Company (NASDAQ: ESRX) today approved the proposed acquisition of Express Scripts by Cigna.
Aug 16, 2018 04:01 pm ET
Express Scripts Reminds Stockholders to Vote "FOR" the Merger with Cigna
ST. LOUIS, Aug. 16, 2018 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) today reminded its stockholders to vote "FOR" Express Scripts' merger agreement with Cigna (NYSE: CI) at the Express Scripts' upcoming Special Meeting of Stockholders (the "Special Meeting") that is scheduled to be held on August 24, 2018, at 9:00 a.m. CT. Express Scripts stockholders who have any questions or need assistance voting their shares should call (800) 690-6903.
Aug 13, 2018 07:24 am ET
Leading Independent Proxy Advisory Firm Glass Lewis Recommends Express Scripts Stockholders Vote "FOR" Merger Agreement with Cigna
ST. LOUIS, Aug. 13, 2018 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) today announced that Glass, Lewis & Co., LLC ("Glass Lewis"), a leading independent proxy advisory firm, has recommended that Express Scripts stockholders vote "FOR" Express Scripts' merger agreement with Cigna (NYSE: CI) at Express Scripts' upcoming special meeting of stockholders scheduled for August 24, 2018.
Aug 10, 2018 01:37 pm ET
Leading Proxy Advisory Firm ISS Recommends Express Scripts Stockholders Vote "FOR" Merger with Cigna
ST. LOUIS, Aug. 10, 2018 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) today announced that Institutional Shareholder Services Inc. ("ISS"), a leading independent proxy advisory firm, has recommended that Express Scripts stockholders vote "FOR" Express Scripts' merger agreement with Cigna (NYSE: CI) at Express Scripts' upcoming special meeting of stockholders scheduled for August 24, 2018.
Aug 09, 2018 01:46 pm ET
Long-term Cigna Shareholder Glenview Capital Submits Open Letter to Shareholders in Support of Cigna / Express Scripts Transaction
NEW YORK, Aug. 9, 2018 /PRNewswire/ --
Aug 07, 2018 08:09 am ET
Express Scripts Announces New Recommendations Tackling High Drug Prices
ST. LOUIS, Aug. 7, 2018 /PRNewswire/ -- Despite drugmaker promises to limit price increases, their ongoing efforts to game the system by delaying generic competition, blocking safe and effective biosimilars and refusing to eliminate list price increases are the main reasons medication remains unaffordable for many people. Today, Express Scripts (NASDAQ:ESRX) is taking action to address these tactics by exposing opportunities within our National Preferred Formulary that will further improve affordability and access for payers and patients.
Aug 01, 2018 04:01 pm ET
Express Scripts Announces 2018 Second Quarter Results
ST. LOUIS, Aug. 1, 2018 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced consolidated 2018 second quarter net income of $877.3 million or $1.55 per diluted share. Consolidated 2018 second quarter adjusted earnings per diluted share were $2.22, which represents growth of 28% over consolidated 2017 second quarter adjusted earnings per diluted share.* The Company increased its 2018 core business¹ adjusted EBITDA* guidance from a range of $5,250 million to $5,400 million to a range of $5,275 million to $5,425 million, which represents growth of 8% over 2017 core business
Jul 26, 2018 03:47 pm ET
SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Cigna Corporation - CI
NEW YORK, July 26, 2018 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Cigna Corporation ("Cigna" or the "Company") (NYSE: CI) relating to the merger of the Company with Express Scripts Holding Company ("Express Scripts") (NasdaqGS: ESRX). As a result of the merger, Cigna will pay Express Scripts shareholders $48.75 in cash and 0.2434 of a share of the newly combined company for each Express Scripts share they own, representing considerati
Jul 18, 2018 08:30 am ET
Express Scripts Subsidiary Expands Services to Healthcare Providers, Adding 100 Jobs in St. Louis
ST. LOUIS and BLUFFTON, S.C., July 18, 2018 /PRNewswire/ -- eviCore healthcare, a subsidiary of Express Scripts Holding Company (NASDAQ: ESRX), is adding 100 jobs in St. Louis as part of expanding its services to healthcare providers.
Jul 12, 2018 06:17 pm ET
WeissLaw LLP Files Class Action Lawsuit Against Express Scripts Holding Company
NEW YORK, July 12, 2018 /PRNewswire/ -- WeissLaw LLP announced that it has filed a class action on behalf of shareholders of Express Scripts Holding Company ("Express Scripts") (NASDAQ: ESRX) seeking to pursue remedies under the Securities Exchange Act of 1934 (the "Exchange Act") in connection with the proposed acquisition of Express Scripts by Cigna Corporation ("Cigna"). The class action was commenced in the United States District Court for the Eastern District of Missouri, Eastern Division.
Jul 12, 2018 11:08 am ET
Express Scripts Holding Company Announces Second Quarter 2018 Earnings Release Details
Express Scripts Holding Company (Nasdaq: ESRX) (“Express Scripts”) announced today its intention to release its 2018 second quarter financial results on Wednesday, August 1, 2018, after the market closes. Management will not be holding a conference...
Jul 11, 2018 04:32 pm ET
Express Scripts Named a Best Place to Work for Disability Inclusion
ST. LOUIS, July 11, 2018 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) was again recognized with a 100 percent score on the Disability Equality Index® (DEI) for its ongoing commitment to being inclusive and welcoming to people of all abilities. The DEI is a national benchmarking tool and joint initiative of the American Association of People with Disabilities and the US Business Leadership Network®.
Jun 28, 2018 05:58 pm ET
SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Express Scripts Holding Co. - ESRX
NEW YORK, June 28, 2018 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Express Scripts Holding Co. ("Express Scripts" or the "Company") (NasdaqGS: ESRX) relating to the sale of the Company to Cigna Corporation ("Cigna"). Under the terms of the agreement, the Company's shareholders will receive $48.75 in cash and 0.2434 of a share of the newly combined company for each Express Scripts share they own, representing consideration of $96.03 per
Jun 12, 2018 08:15 am ET
Detailed Research: Economic Perspectives on Southern, AcelRx Pharmaceuticals, International Flavors & Fragrances, Pandora Media, Express Scripts Holding, and United Continental — What Drives Growth in
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Southern Company (NYSE:SO), AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX),...
Jun 07, 2018 11:08 am ET
Express Scripts' Physician-Minded Solutions Deliver Greater Price Transparency, Medication Safety and Coordination of Care
ST. LOUIS, June 7, 2018 /PRNewswire/ -- A suite of high-impact, data-driven engagement programs from Express Scripts (NASDAQ: ESRX) are simplifying the prescribing experience for physicians and providers, helping them make better clinical and cost-effective decisions with their patients right at the point-of-care. The solutions are part of the industry's most comprehensive effort to champion a simpler pharmacy experience by improving connectivity and easing the administrative burden for physicians and their staff.
Jun 06, 2018 08:07 am ET
Pharmacy Everywhere: Express Scripts and MedAvail Announce Collaboration to Make Pharmacy More Affordable and Convenient
ST. LOUIS, June 6, 2018 /PRNewswire/ -- Convenience is the new currency among consumers looking for faster, easier, always-accessible services to conform to their daily lives. As a result, the economy's next big evolution may impact how tens of millions of people get their prescription drugs. That's the vision of Express Scripts (NASDAQ: ESRX), which today announced a strategic investment in MedAvail, a leading healthcare technology company behind self-service pharmacy centers.
Jun 04, 2018 08:44 am ET
VFW Selects Inside Rx to Offer a Free Drug Savings Card to Members and Their Families
FRANKLIN LAKES, N.J., June 4, 2018 /PRNewswire/ -- Inside Rx today announced an agreement with the Veterans of Foreign Wars of the U.S. (VFW) to offer easy access to its 1.3 million members and their families who can benefit from the free Inside Rx savings card that provides deep discounts to the uninsured and underinsured who pay cash for their prescription medications. The Inside Rx card can be used in any of the more than 40,000 participating pharmacies in the U.S. and offers more than 125 brand-name medications at a savings average of 40 percent, and a robust list of generics with an ave
May 31, 2018 08:07 am ET
Express Scripts to Provide Patients with Faster Path to Rare Disease Diagnosis and Treatment, in Collaboration with PinnacleCare
ST. LOUIS and BALTIMORE, May 31, 2018 /PRNewswire/ -- For any patient with a rare disease, the journey to the right diagnosis and treatment can be long and difficult. On average, it can take 7.6 years and seven different doctors before a patient suffering from the symptoms of a rare disease finally receives a correct diagnosis. Even then, determining the best treatment and managing the complexities of any rare disease can require expertise that many physicians lack given the relatively small patient population affected by the condition. Many times, a second opinion from an expert can help re
May 16, 2018 11:13 am ET
Inside Rx Prescription Savings Program Marks First Anniversary By Achieving $100 Million Savings Milestone
FRANKLIN LAKES, N.J., May 16, 2018 /PRNewswire/ -- In just one year, customers of the Inside Rx® prescription savings program collectively have saved $100 million on their medications. Inside Rx, launched by Express Scripts (NASDAQ:ESRX) in May of 2017, is celebrating its first year of providing deep discounts on more than 125 brand-name medications, and a robust list of generic medications, for Americans who are uninsured or pay out-of-pocket for their prescriptions.
May 11, 2018 02:58 pm ET
Express Scripts Statement on Administration's Comments on Drug Pricing
ST. LOUIS, May 11, 2018 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) released the following statement in response to the Administration's announcement today on prescription drug costs:
May 10, 2018 09:30 am ET
Innovative Value-based SafeGuardRx® Program Delivers Better Care at Lower Cost for Express Scripts' Patients and Plan Sponsors
ST. LOUIS, May 10, 2018 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) released new data today showing significantly improved clinical outcomes and lower drug spending for patients with complex, high-cost conditions who are enrolled in a suite of technology-supported, value-based SafeGuardRx® programs.
May 03, 2018 09:30 am ET
Inside Rx, a Prescription Savings Program from Express Scripts, Expands List of Discounted Brand-Name Medications
FRANKLIN LAKES, N.J., May 3, 2018 /PRNewswire/ -- Inside RxSM, a pharmacy savings program from Express Scripts (NASDAQ:ESRX), today announced that it is making an additional 22 brand-name medications more affordable for people who currently have to pay the full list price for prescriptions. With the addition of these new products, Inside Rx now provides affordable access to more than 120 brand-name medications, adding discounted drugs for eight new therapy classes and expanding the program's current list of medications in five therapy classes for conditions that are prevalent in the U.S.
May 02, 2018 04:21 pm ET
Express Scripts Announces 2018 First Quarter Results
ST. LOUIS, May 2, 2018 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced consolidated 2018 first quarter net income of $623.2 million or $1.10 per diluted share. Consolidated 2018 first quarter adjusted earnings per diluted share was $1.77.* The Company reaffirms its core business¹ 2018 adjusted EBITDA* guidance in the range of $5,250 million to $5,400 million, which represents growth of 8% over core business 2017 adjusted EBITDA at the midpoint of the range.
May 02, 2018 12:00 pm ET
Express Scripts Ranked as a Top 50 Inclusive company by DiversityInc
ST. LOUIS, May 2, 2018 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX), through its commitment to diversity and inclusion, has earned recognition among the Top 50 inclusive companies in the nation by DiversityInc, it was announced today.
Apr 30, 2018 10:30 am ET
Saratoga County Announces New Partnership with Inside Rx for County Prescription Drug Discount Program
STILLWATER, N.Y., April 30, 2018 /PRNewswire/ -- Saratoga County today announced an agreement with Inside Rx to offer the Inside RxSM discount savings card to Saratoga County residents as part of the County's Prescription Drug Discount Program. This program has been developed by the Saratoga County Board of Supervisors to help lower the prescription drug cost for County residents.
Apr 25, 2018 07:00 am ET
"Knowing But Not Doing: The State of Rx Adherence in America Report" Finds Big Difference in What Americans Know and Do When It Comes to Their Chronic Medications
ST. LOUIS, April 25, 2018 /PRNewswire/ -- Many Americans on medications for chronic diseases are not concerned about missing doses, resent their spouses/partners reminding them to take their medicine and think they do a better job than others at taking their medication as prescribed. That's according to a new survey, Knowing But Not Doing: The State of Rx Adherence in America Report from Express Scripts (NASDAQ: ESRX).
Apr 13, 2018 02:42 pm ET
Express Scripts Holding Company Announces First Quarter 2018 Earnings Release Details
St. Louis, April 13, 2018 (GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq: ESRX) (“Express Scripts”) announced today its intention to release its 2018 first quarter financial results on Wednesday, May 2, 2018, after the market closes. Management...
Apr 12, 2018 08:00 am ET
Express Scripts Launches Innovative Pilot Program For Performance-based Retail Pharmacy Network for Commercial Plans
ST. LOUIS, April 12, 2018 /PRNewswire/ -- Guided by the principles of simplification, choice, and competition, Express Scripts (NASDAQ: ESRX) today announced the launch of a new, innovative 12-month pilot for a performance-based retail pharmacy network for commercial plans designed to optimize medication therapy, improve medication adherence, and promote better outcomes. The pilot will examine the impact of rewarding pharmacies that fill prescriptions for Express Scripts members and demonstrate a positive improvement on individual members' medication adherence for conditions such as diabete
Apr 10, 2018 08:00 am ET
U.S. Workers' Compensation Prescription Drug Spending Decreased 3.3 Percent in 2017
ST. LOUIS, April 10, 2018 /PRNewswire/ -- Workers' compensation pharmacy spending decreased 3.3 percent in 2017, according to new data released by myMatrixx, an Express Scripts (NASDAQ: ESRX) company.
Apr 03, 2018 04:01 pm ET
Express Scripts Names Ron Guerrier Chief Information Officer
ST. LOUIS, April 3, 2018 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) today announced that Ron Guerrier will join the company as Chief Information Officer, effective April 16, 2018. He will be responsible for the company's strategic investments in and application of technology to improve affordability and access to prescription drugs for the 80 million people the company serves.
Apr 02, 2018 04:00 pm ET
Express Scripts Names Mike Cirillo President of myMatrixx
ST. LOUIS, April 2, 2018 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) today announced that Mike Cirillo has been named President of myMatrixx, an Express Scripts company. Mike will replace Artemis Emslie, who will stay with myMatrixx until the end of May to assist with the transition.
Mar 21, 2018 01:10 pm ET
/DISREGARD RELEASE: Kahn Swick & Foti, LLC/
We are advised by Kahn Swick & Foti, LLC that journalists and other readers should disregard the news release, EXPRESS SCRIPTS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Express Scripts Holding Company, issued 09-Mar-2018 over PR Newswire.
Mar 20, 2018 02:52 pm ET
Mar 16, 2018 03:29 pm ET
Express Scripts Endorses "Know the Lowest Price Act of 2018" and "Patient Right to Know Drug Prices Act"
ST. LOUIS, March 16, 2018 /PRNewswire/ -- Express Scripts (NASDAQ:ESRX) today released this statement in support of S. 2553, the "Know the Lowest Price Act of 2018," introduced by U.S. Senators Stabenow, Collins, Wyden, Cassidy, McCaskill and Barrasso, and S. 2554, the "Patient Right to Know Drug Prices Act," introduced by U.S. Senators Collins, McCaskill, Barrasso, Stabenow and Cassidy.
Mar 14, 2018 02:33 pm ET
Express Scripts Holding Company to Cancel Investor Day Meeting
ST. LOUIS, March 14, 2018 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) ("Express Scripts") announced today it cancelled its previously announced investor day meeting, which was scheduled to be held in New York City on May 2, 2018, at 8:00 a.m. Eastern Time (7:00 a.m. Central Time) at The Roosevelt Hotel New York. The cancellation is due to the recent announcement that Cigna and Express Scripts have entered into an Agreement and Plan of Merger.
Mar 13, 2018 04:15 pm ET
A.M. Best Places Credit Ratings of Medco Containment Life Insurance Company and Medco Containment Insurance Company of New York Under Review With Developing Implications
A.M. Best has placed under review with developing implications
the Financial Strength Rating of A- (Excellent) and Long-Term Issuer
Credit Rating of “a-” of Medco Containment Life Insurance Company
(Mechanicsburg, PA) and Medco Containment Insurance Company of New
York (Troy, NY) (collectively referred to as Medco Containment
Group). Both companies are subsidiaries of Express Scripts
Holding Company (Express Scripts) [NASDAQ: ESRX].
Mar 12, 2018 01:03 pm ET
WeissLaw LLP Investigates Express Scripts Holding Co. Acquisition
NEW YORK, March 12, 2018 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Express Scripts Holding Co. ("ESRX" or the "Company") (NASDAQ: ESRX) in connection with the proposed acquisition of the Company by Cigna Corp. ("CI") (NYSE: CI). On March 8, 2018, the Company announced a definitive agreement for CI to acquire all outstanding shares of ESRX in a cash-and-stock deal. Under the terms of the agreement, the Company's shareholders will receive $48.75 in cash and 0.2434 of a share of the newly combined
Mar 09, 2018 10:31 am ET
EXPRESS SCRIPTS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Express Scripts Holding Company
NEW ORLEANS, March 9, 2018 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Express Scripts Holding Company ("Express" or the "Company") (NasdaqGS: ESRX) to Cigna Corporation (NYSE: CI). Under the terms of the proposed transaction, shareholders of Express will receive only $48.75 in cash and 0.2434 shares of the combined company's stock for each share of Express that they own. KSF is seeking to determine whether this consideration and the process that led to it are ad
Mar 08, 2018 11:53 am ET
Mar 08, 2018 11:12 am ET
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Express Scripts Holding Company to Cigna Corporation is Fair to Shareholders – ESRX
The following statement is being issued by Levi & Korsinsky, LLP:
Mar 08, 2018 09:51 am ET
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Express Scripts Holding Company
NEW YORK, March 8, 2018 /PRNewswire/ -- Rowley Law PLLC is investigating potential claims against Express Scripts Holding Company (NASDAQ: ESRX) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company by Cigna Corp. Stockholders will receive $48.75 and 0.2434 shares of Cigna Corp. common stock for each share of Express Scripts stock that they hold. The transaction is valued at approximately $67 billion and is expected to close by December 31, 2018.
Mar 08, 2018 07:16 am ET
Express Scripts (ESRX) Alert: Johnson Fistel Investigates Proposed Sale of Express Scripts; Are Shareholders getting a Fair Price?
SAN DIEGO, March 8, 2018 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Express Scripts Holding Company ("Express Scripts") (NASDAQ: ESRX) breached their fiduciary duties in connection with the proposed sale of the Company to Cigna Corp. ("Cigna") (NYSE: CI).
Mar 08, 2018 06:00 am ET
Cigna to Acquire Express Scripts for $67 Billion
Cigna Corporation (NYSE: CI) and Express Scripts Holding Company
(NASDAQ: ESRX) today announced that they have entered into a definitive
agreement whereby Cigna will acquire Express Scripts in a cash and stock
transaction valued at approximately $67 billion, including Cigna's
assumption of approximately $15 billion in Express Scripts debt. The
merger consideration will consist of $48.75 in cash and 0.2434 shares of
stock of the combined company per Express Scripts share. The transaction
was approved by the board of directors of each company.
Mar 06, 2018 04:03 pm ET
Express Scripts Awarded National Recognition for Fighting the Opioid Epidemic
ST. LOUIS, March 6, 2018 /PRNewswire/ -- On Tuesday, Express Scripts (NASDAQ: ESRX) was awarded the Pharmacy Benefit Management Institute's (PBMI) Excellence Award in the Opioid Management Strategy Category. The award comes in recognition of the ground breaking ways Express Scripts is helping plan sponsors fight the serious dangers of opioid misuse and abuse.
Feb 27, 2018 03:01 pm ET
Express Scripts Announces 2017 Fourth Quarter and Full Year Results
ST. LOUIS, Feb. 27, 2018 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced consolidated 2017 fourth quarter and full year net income of $2,327.6 million and $4,517.4 million, respectively, or $4.10 and $7.74 per diluted share, respectively. Consolidated 2017 fourth quarter and full year adjusted earnings per diluted share were $2.16 and $7.10, respectively.*
Feb 21, 2018 08:25 am ET
Express Scripts Holding Company Announces Webcast of Investor Day Meeting
ST. LOUIS, Feb. 21, 2018 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) ("Express Scripts") announced today it has scheduled an investor day meeting in New York City on May 2, 2018, at 8:00 a.m. Eastern Time (7:00 a.m. Central Time) at The Roosevelt Hotel New York. At the meeting, senior leaders will discuss the Company's future outlook, its strategy of creating value for patients and clients and how its innovative tools and solutions position the Company for the future of healthcare.
Feb 21, 2018 07:35 am ET
Recent Analysis Shows EchoStar, Toro, Genesee & Wyoming, Express Scripts Holding, D.R. Horton, and Mirati Therapeutics Market Influences — Renewed Outlook, Key Drivers of Growth
NEW YORK, Feb. 21, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of EchoStar Corporation (NASDAQ:SATS), Toro Company (NYSE:TTC),...
Feb 20, 2018 03:01 pm ET
Express Scripts and Walgreens Boots Alliance Expand Group Purchasing Efforts to Include Specialty Brand Medications
ST. LOUIS and DEERFIELD, Ill., Feb. 20, 2018 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) and Walgreens Boots Alliance, Inc. (NASDAQ: WBA) today announced they are expanding their group purchasing efforts to include the procurement of specialty brand drugs. Given the savings potential associated with biosimilars in the coming years, the two companies believe this expansion is particularly timely.
Feb 20, 2018 06:00 am ET
Inside Rx Pets Savings Program Helps Pet Parents Save Big
FRANKLIN LAKES, N.J., Feb. 20, 2018 /PRNewswire/ -- Pet parents of dogs, cats, hamsters, reptiles and even monkeys can now more easily afford their pet's prescribed medications with the Inside Rx PetsSM discount card, which can offer an average savings of 75 percent off generics and up to 15 percent off brand medications. The Inside Rx Pets program is offered by Inside Rx, LLC, a partially owned subsidiary of Express Scripts (NASDAQ:ESRX), which also offers the Inside RxSM prescription savings card.
Feb 06, 2018 09:59 am ET
Express Scripts Reduces Employers' Annual Prescription Drug Spending Growth Rate to Historic Low in 2017
ST. LOUIS, Feb. 6, 2018 /PRNewswire/ -- At a time when consumers, businesses and policymakers are intensely focused on reducing prescription drug costs, Express Scripts (NASDAQ: ESRX) helped employers reduce the rate of growth in per-person prescription drug spending to 1.5 percent in 2017, according to the 2017 Express Scripts Drug Trend Report released today. While this growth rate is the lowest Express Scripts has measured since 1993, there is more to be done to make prescription medications more affordable for working families, seniors and the disabled.
Feb 05, 2018 07:00 am ET
Inside Rx Provides Savings on Influenza Medications
FRANKLIN LAKES, N.J., Feb. 5, 2018 /PRNewswire/ -- Inside Rx today announced that it is now offering better pricing on the brand and generic versions of Tamiflu® (oseltamivir phosphate) to help Americans affected by what the Centers for Disease Control and Prevention (CDC) has called the worst recorded influenza season in almost a decade. Launched last year by Express Scripts (NASDAQ: ESRX), the Inside RxSM prescription savings program can provide deeper savings to people who pay full-list price for prescription medications.
Jan 17, 2018 06:00 am ET
Super Savings: Inside Rx Expands Its Prescription Savings Program, Offers Discounts on 100 Brand Name Medications
FRANKLIN LAKES, N.J., Jan. 17, 2018 /PRNewswire/ -- Inside Rx announced today the addition of 30 new brand-name prescription medications to its featured medications list, bringing the total number of discounted brand medications available through the ground-breaking program to 100. The Inside RxSM program, launched last year by Express Scripts (NASDAQ: ESRX), can provide affordable access to uninsured people who pay full-list price for prescription medications.
Jan 15, 2018 01:54 pm ET
Express Scripts Holding Company Announces Fourth Quarter and Full Year 2017 Earnings Conference Call
St. Louis, Jan. 15, 2018 (GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq: ESRX) (“Express Scripts”) announced today its intention to release its 2017 fourth quarter and full year financial results on Tuesday, February 27, 2018, after the...
Jan 11, 2018 01:00 pm ET
Safer Opioid Prescribing: Express Scripts Significantly Reduces Inappropriate Selection and Excessive Dispensing of Opioids for New Patients
WASHINGTON, Jan. 11, 2018 /PRNewswire/ -- During a briefing on meaningful solutions for safer opioid prescribing with Congressional Representatives Ann McLane Kuster (D-NH) and Tom MacArthur (R-NJ), Express Scripts (NASDAQ: ESRX) today announced that an initial 90-day review of its Advanced Opioid ManagementSM program shows that the comprehensive solution is protecting people using an opioid medication, particularly those taking an opioid for the first time.
Jan 10, 2018 08:00 am ET
Express Scripts' Accredo Earns Renewed URAC Specialty Pharmacy Accreditation
ST. LOUIS, Jan. 10, 2018 /PRNewswire/ -- Accredo® specialty pharmacy, a subsidiary of Express Scripts (NASDAQ: ESRX), has earned URAC's specialty pharmacy accreditation at its primary dispensing locations: Warrendale, Pa., New Castle, Del., Indianapolis, Ind., Orlando, Fla., Memphis, Tenn., Greensboro, N.C., Nashville, Tenn., and Corona, Calif.
Jan 10, 2018 07:00 am ET
Inside Rx En Español: Company Launches Spanish Language Website for Consumers Seeking Discounts on Prescription Medications
FRANKLIN LAKES, N.J., Jan. 10, 2018 /PRNewswire/ -- Inside Rx, which administers a prescription savings program for the uninsured and underinsured, is helping more people access savings to prescription medications today with the launch of a Spanish-language version of the company's website, https://insiderx.com/es. Inside Rx, a partially owned subsidiary of Express Scripts (NASDAQ:ESRX), provides affordable access to brand and generic medications, delivering an average savings of 40 percent on select brand name prescription medications for the uninsured and those who experience high out-of-p
Jan 02, 2018 04:31 pm ET
Express Scripts Holding Company to Present at the J.P. Morgan Healthcare Conference
ST. LOUIS, Jan. 2, 2018 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) ("Express Scripts") announced today that it will present at the J.P. Morgan Healthcare Conference on Monday, January 8, 2018 at 3:00 p.m. Pacific Standard Time (6:00 p.m. Eastern Standard Time).
Dec 15, 2017 03:10 pm ET
Express Scripts Closes Acquisition Of eviCore; Companies Unite To Improve Healthcare For 100 Million Americans
ST. LOUIS and BLUFFTON, S.C., Dec. 15, 2017 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) today announced that it has completed the acquisition of privately held eviCore healthcare, the industry leader in evidence-based medical benefit management services, for $3.6 billion. Beginning today, eviCore contributes to Express Scripts' overall growth and ability to deliver improved clinical outcomes and savings for health plans, purchasers and patients.
Dec 14, 2017 06:30 am ET
Express Scripts Holding Company Updates 2017 Full-Year Guidance and Announces 2018 Financial Guidance
ST. LOUIS, Dec. 14, 2017 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) increased its previously issued consolidated 2017 full-year adjusted EPS guidance range of $6.97 to $7.05 to $7.00 to $7.08, which represents growth of 10% over consolidated 2016 adjusted EPS results at the midpoint of the range. The Company narrowed its previously issued consolidated 2017 adjusted EBITDA1 guidance from a range of $7,350 million to $7,470 million to a range of $7,370 million to $7,450 million, which maintains the midpoint of the range and represents growth of 2% over consolidated 2016 a
Dec 05, 2017 05:00 am ET
New Research: Key Drivers of Growth for Express Scripts Holding, D.R. Horton, Mirati Therapeutics, EchoStar, Toro, and Genesee & Wyoming — Factors of Influence, Major Initiatives and Sustained Product
NEW YORK, Dec. 05, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Express Scripts Holding Company (NASDAQ:ESRX), D.R....
Nov 27, 2017 08:15 am ET
Avista Capital Partners to Acquire Express Scripts' Subsidiary United BioSource
ST. LOUIS and NEW YORK, Nov. 27, 2017 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) and Avista Capital Partners, a leading private equity firm, announced today that Avista has signed a definitive agreement to acquire United BioSource (UBC), a wholly-owned subsidiary of Express Scripts Holding Company.
Nov 16, 2017 06:00 am ET
Propeller Health and Express Scripts Partnership Offers Innovative Digital Respiratory Care to Improve Health for People with Asthma or COPD
MADISON, Wis. and ST. LOUIS, Nov. 16, 2017 /PRNewswire/ -- Today, Propeller Health and Express Scripts (NASDAQ: ESRX) announced a strategic partnership to provide Propeller's FDA-cleared digital solution to Express Scripts members using inhaler sensors and a mobile app to manage asthma or COPD. This collaboration is the largest respiratory digital health deployment with a pharmacy benefit manager to date.
Nov 09, 2017 03:00 pm ET
Express Scripts Holding Company Announces 2018 Financial Guidance Conference Call
ST. LOUIS, Nov. 9, 2017 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) today announced its intention to release its 2018 financial guidance on Thursday, December 14, 2017, via press release before the market opens, followed by a conference call to discuss the 2018 financial guidance at 8:30 a.m. Eastern Time (7:30 a.m. Central Time) on Thursday, December 14, 2017. The conference call will feature remarks by Tim Wentworth, President and CEO, and Jim Havel, CFO.
Nov 09, 2017 01:41 pm ET
Express Scripts Recognized as a Best Place to Work for LGBTQ Equality
ST. LOUIS, Nov. 9, 2017 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) has received a perfect score of 100 on the 2018 Corporate Equality Index, a national benchmarking report on corporate policies and practices related to lesbian, gay, bisexual, transgender and queer (LGBTQ) workplace equality, administered by the Human Rights Campaign Foundation.
Nov 06, 2017 08:20 am ET
Market Trends Toward New Normal in Public Service Enterprise Group, Rigel Pharma, National Oilwell Varco, Ironwood Pharma, Express Scripts, and Synergy Pharma – Emerging Consolidated Expectations, Ana
NEW YORK, Nov. 06, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Public Service Enterprise Group Incorporated (NYSE:PEG),...
Oct 30, 2017 05:38 pm ET
Express Scripts Holding Company to Present at an Upcoming Conference
ST. LOUIS, Oct. 30, 2017 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) ("Express Scripts") announced today that it will present at the Credit Suisse Annual Healthcare Conference on Tuesday, November 7, 2017 at 9:45 a.m. MST (11:45 a.m. EST).
Oct 24, 2017 05:07 pm ET
Express Scripts Appoints James M. Havel Chief Financial Officer
ST. LOUIS, Oct. 24, 2017 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) today announced that James M. Havel, who previously served as Express Scripts' Executive Vice President, has been named Executive Vice President and Chief Financial Officer, effective October 25, 2017. Eric Slusser, Executive Vice President and Chief Financial Officer, is leaving the Company to pursue other opportunities, but will stay with the Company through the first quarter of 2018 in order to ensure a smooth transition.
Oct 24, 2017 05:01 pm ET
Express Scripts Announces 2017 Third Quarter Results
ST. LOUIS, Oct. 24, 2017 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced 2017 third quarter net income of $841.7 million or $1.46 per diluted share. 2017 third quarter adjusted earnings per diluted share was $1.90.*
Oct 18, 2017 07:00 am ET
New Research: Affordability and Access to Prescription Medications Take Center Stage in Selecting a Medicare Plan
ST. LOUIS, Oct. 18, 2017 /PRNewswire/ -- Medicare can be an alphabet soup (Part D; MA-PD; MA), but according to research released today by Express Scripts (NASDAQ: ESRX), seniors understand the value offered by these plans, especially when it comes to prescription medications.
Oct 10, 2017 10:00 am ET
Express Scripts to Acquire eviCore healthcare; Accelerates Company's Shift to Patient Benefit Management
ST. LOUIS and BLUFFTON, S.C., Oct. 10, 2017 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) today announced that it has reached an agreement to acquire privately-held eviCore healthcare, the industry leader in evidence-based medical benefit management services, for $3.6 billion. Combining Express Scripts' leading pharmacy benefit management offering and eviCore's highly complementary medical benefits management (MBM) platform will create a uniquely comprehensive patient benefit management solution.
Oct 03, 2017 07:00 am ET
A New Normal? 870,000 Americans Used $50,000 Worth or More of Prescription Medicine in 2016
ST. LOUIS, Oct. 3, 2017 /PRNewswire/ -- A small but steadily growing number of Americans account for an increasingly significant amount of the nation's overall prescription drug bill, according to new research released today by Express Scripts (NASDAQ: ESRX).
Oct 02, 2017 08:36 am ET
Express Scripts Introduces New Medicare Part D Saver Plan for 2018
ST. LOUIS, Oct. 2, 2017 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) today introduced a new Express Scripts Medicare® Prescription Drug Plan (PDP) for 2018 called the Saver plan, a low-premium Part D plan that provides affordable access to nearly 3,000 commonly used medications and a preferred pharmacy network with CVS Pharmacy and the Kroger Family of Pharmacies.
Sep 07, 2017 05:23 pm ET
Express Scripts Offers Important Prescription Drug Information for Residents Impacted by Hurricane Irma
ST. LOUIS, Sept. 7, 2017 /PRNewswire/ -- Express Scripts is providing the following information to assist residents impacted by Hurricane Irma in Florida, Georgia and Puerto Rico who have prescription coverage through Express Scripts.
Aug 30, 2017 05:20 pm ET
Express Scripts Holding Company to Present at an Upcoming Conference
ST. LOUIS, Aug. 30, 2017 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) ("Express Scripts") announced today that it will present at the 2017 Wells Fargo Healthcare Conference on Wednesday, September 6, 2017 at 9:05 a.m. eastern (8:05 a.m. central).
Aug 25, 2017 07:00 am ET
Express Scripts Research Shows Significant Benefit of Adherence to Diabetes Medications
ST. LOUIS, Aug. 25, 2017 /PRNewswire/ -- New research released today by Express Scripts (NASDAQ: ESRX) reveals that commercially insured people who were adherent to their oral diabetes medications experienced significantly fewer emergency room visits and inpatient hospitalizations, and spent nearly $500 less on total healthcare costs compared to nonadherent patients, potentially avoiding more than $210 million in healthcare spending in 2016.
Aug 23, 2017 09:05 am ET
Express Scripts Named a Best Place to Work for Disability Inclusion
ST. LOUIS, Aug. 23, 2017 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) was recognized today as a top-scoring company on the Disability Equality Index® (DEI) for having inclusive workplace, social and governance policies. The DEI is a national benchmarking tool and joint initiative of the American Association of People with Disabilities and the US Business Leadership Network®.
Aug 22, 2017 07:00 am ET
Inside Rx Expands Program To More Than 60 Prescription Brand Medications; Saves Americans More Than $1 Million Since Launch
FRANKLIN LAKES, N.J., Aug. 22, 2017 /PRNewswire/ -- Inside Rx, a new venture launched in May by Express Scripts (NASDAQ: ESRX) that provides affordable access to patients paying full list price for prescription medications, is expanding the list of discounted medications available to include 18 new products – 63 in total -- effective today.
Jul 31, 2017 10:15 am ET
The Value of Active Pharmacy Management: Express Scripts 2018 National Preferred Formulary
ST. LOUIS, July 31, 2017 Deciding which medicines to include on the nation's largest drug list starts where it should: by determining which medicines deliver the best outcomes for patients.
Jul 25, 2017 05:01 pm ET
Express Scripts Announces 2017 Second Quarter Results
ST. LOUIS, July 25, 2017 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced 2017 second quarter net income of $801.8 million or $1.37 per diluted share. 2017 second quarter adjusted earnings per diluted share was $1.73.*
Jun 27, 2017 05:47 pm ET
Express Scripts Elects Kathleen M. Mazzarella to Board of Directors
ST. LOUIS, June 27, 2017 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) today announced the election of Kathleen M. Mazzarella to the company's Board of Directors effective June 27, 2017.
Jun 22, 2017 06:29 pm ET
A Nation in Pain: Focus on Medicaid
ST. LOUIS, June 22, 2017 /PRNewswire/ -- Our nation's unprecedented opioid epidemic has been called the worst drug crisis in American history. To highlight the severity of this issue, consider these few alarming statistics:
Jun 07, 2017 09:45 am ET
Express Scripts Introduces Comprehensive Solution to Reduce Opioid Abuse
ST. LOUIS, June 7, 2017 /PRNewswire/ -- Building upon its history of industry-leading bold actions, Express Scripts (NASDAQ: ESRX) today announced a new Advanced Opioid ManagementSM solution that will better address our nation's opioid-addiction epidemic by working comprehensively with patients, prescribers and pharmacies to minimize early exposure while helping prevent progression to overuse and abuse.
Jun 05, 2017 04:20 pm ET
Express Scripts Holding Company to Present at Upcoming Conferences
ST. LOUIS, June 5, 2017 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) ("Express Scripts") announced today that it will present at two upcoming conferences:
Jun 01, 2017 09:00 am ET
Express Scripts Expands SafeGuardRx® Program to Improve Care for Pulmonary Conditions and Multiple Sclerosis
ST. LOUIS, June 1, 2017 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) today extended its leadership in innovative, value-based care with two new Express Scripts SafeGuardRx® programs: the Pulmonary Care Value ProgramSM and the Multiple Sclerosis Care Value ProgramSM. These solutions leverage the core strengths of Express Scripts' independent model, and combine technology, specialized care and strategic industry collaborations, to deliver greater value to payers and improved health outcomes for patients living with these chronic, complex and costly illnesses.
May 18, 2017 10:00 am ET
Express Scripts Subsidiary to Join Walgreens Boots Alliance Development Group Purchasing Organization
ST. LOUIS, May 18, 2017 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX), through a wholly owned subsidiary, Innovative Product Alignment, LLC, today announced it will participate in Walgreens Boots Alliance Development GmbH (WBAD) group purchasing organization. In addition, Econdisc Contracting Solutions, a group purchasing organization that contracts with manufacturers to source generic pharmaceuticals on behalf of its participants, will have access to WBAD's sourcing efforts through an arrangement between Econdisc and Innovative Product Alignment. These two organizations wil
May 17, 2017 05:00 pm ET
Express Scripts and myMatrixx Combine To Offer Best-in-Class Pharmacy Services for Workers' Compensation Programs
ST. LOUIS, May 17, 2017 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) today announced it is taking an important step in expanding its customized workers' compensation pharmacy solutions by acquiring myMatrixx, a pharmacy benefit solutions provider for the workers' compensation industry. The companies will merge core capabilities to deliver best-in-class clinical expertise, advanced analytics, and customized client experiences to serve workers' compensation clients and injured patients.
May 08, 2017 06:26 pm ET
Express Scripts Holding Company to Present at an Upcoming Conference
ST. LOUIS, May 8, 2017 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) ("Express Scripts") announced today that it will present at the Bank of America Merrill Lynch 2017 Health Care Conference on Tuesday, May 16, 2017 at 11:20 a.m. pacific (2:20 p.m. eastern).
May 08, 2017 09:15 am ET
Cross-Industry Partnership Reduces The Cost Of Popular Diabetes, Asthma And Other Brand Name Drugs
ST. LOUIS and SANTA MONICA, Calif., May 8, 2017 /PRNewswire/ -- Today, Express Scripts (NASDAQ: ESRX) announced the launch of Inside Rx, a new, partially owned subsidiary that applies Express Scripts' purchasing power to expand affordable access to brand and generic medications for patients in need. Inside Rx has partnered with GoodRx, America's leading source for prescription drug prices and savings, to deliver average savings of 34 percent on prescription medications for the uninsured and those who experience high out-of-pocket costs for their prescription medications.
May 05, 2017 03:00 pm ET
Express Scripts Recognized Among Most Diverse U.S. Companies by DiversityInc
ST. LOUIS, May 5, 2017 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) has been recognized by DiversityInc as a "Noteworthy" company for diversity, based on its hiring, retention, and promotion of women, minorities, people with disabilities, LGBT individuals, and veterans.
Apr 28, 2017 08:17 pm ET
Apr 27, 2017 01:00 pm ET
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Express Scripts Holding Company (ESRX)
NEW YORK, April 27, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Express Scripts Holding Company ("Express Scripts" or the "Company") (NasdaqGS: ESRX). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/esrx.
Apr 24, 2017 11:01 pm ET
EXPRESS SCRIPTS ALERT: J&W Announces Investigation of Express Scripts; Expects to Lose Biggest Customer, Investors Encouraged to Contact Firm
SAN DIEGO, April 24, 2017 /PRNewswire/ -- Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating potential violations of the federal securities laws by Express Scripts Holding Company (NASDAQ: ESRX) and certain of its officers. Express Scripts operates as a pharmacy benefit management (PBM) company in the United States, Canada, and Europe.
Apr 24, 2017 05:01 pm ET
Express Scripts Announces 2017 First Quarter Results; Provides Update on Anthem Relationship and Visibility into Core PBM Business Excluding Contribution from Anthem, Coventry and Catamaran
ST. LOUIS, April 24, 2017 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced 2017 first quarter net income of $546.3 million or $0.90 per diluted share. The 2017 first quarter adjusted earnings per diluted share was $1.33.*
Apr 11, 2017 05:00 pm ET
Express Scripts Holding Company Announces First Quarter 2017 Earnings Conference Call
St. Louis, April 11, 2017 (GLOBE NEWSWIRE) -- ...
Apr 04, 2017 08:00 am ET
U.S. Workers' Compensation Prescription Drug Spending Decreased 7.6% in 2016 Through Cost-Savings Solutions, Improved Care for Injured Workers
ST. LOUIS, April 4, 2017 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) lowered prescription drug spending for workers' compensation payers by 7.6 percent in 2016, according to the 11th edition of its Workers' Compensation Drug Trend Report.
Mar 15, 2017 10:00 am ET
Mango Health Announces Partnership, Strategic Investment from Express Scripts
SAN FRANCISCO, March 15, 2017 /PRNewswire-USNewswire/ -- Mango Health, a mobile health company, today announced a long term operating partnership with Express Scripts (NASDAQ: ESRX) which will include a new daily health management platform to improve health outcomes. Through the partnership, Mango Health's innovative patient-facing mobile applications will be available to Express Scripts' clients, representing more than 85 million Americans. In addition to the operating partnership, Express Scripts has made a strategic investment in Mango Health.
Mar 07, 2017 01:34 pm ET
Express Scripts Holding Company to Present at the Barclays Global Healthcare Conference
ST. LOUIS, March 7, 2017 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) ("Express Scripts") announced today that it will present at the Barclays Global Healthcare Conference on Wednesday, March 15, 2017 at 9:30 a.m. Eastern Daylight Time at the Loews Miami Beach Hotel in Miami Beach, FL. At the meeting, the Company may make forward-looking statements, including but not limited to our 2017 full year and quarterly guidance and statements related to how the Company creates value for patients, clients and shareholders through our unique model of alignment, balanced growth driver
Feb 28, 2017 05:00 pm ET
High Drug Prices Frustrate Government-Sponsored Health Programs, According to New Express Scripts Drug Trend Insights
ST. LOUIS, Feb. 28, 2017 /PRNewswire/ -- Health plans partnering with Express Scripts are delivering high-quality, affordable pharmacy care to millions of individuals enrolled in government-sponsored programs, but this record is at risk without decisive action to advance additional pro-patient and pro-payer policy changes, according to new research released today by Express Scripts (NASDAQ: ESRX).
Feb 16, 2017 04:11 pm ET
Express Scripts Named one of Fortune Magazine's World's Most Admired Companies of 2017
ST. LOUIS, Feb. 16, 2017 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) was recognized today by Fortune Magazine as one of the World's Most Admired Companies within the Health Care: Pharmacy and Other Services category.
Feb 14, 2017 04:01 pm ET
Express Scripts Announces 2016 Fourth Quarter and Full Year Results
ST. LOUIS, Feb. 14, 2017 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced 2016 fourth quarter and full year net income of $1,434.7 million and $3,404.4 million, respectively, or $2.34 and $5.39 per diluted share, respectively. 2016 fourth quarter and full year adjusted earnings per diluted share, as detailed in Table 4, was $1.88 and $6.39, respectively.1
Feb 06, 2017 06:00 am ET
Express Scripts Fights Back Against Irresponsible Drug Pricing; Holds U.S. Drug Spending Increase to 3.8 Percent in 2016
ST. LOUIS, Feb. 6, 2017 /PRNewswire/ -- Express Scripts' (NASDAQ: ESRX) efforts to put medicine within reach for payers and patients effectively held the 2016 growth rate in prescription drug spending to just 3.8 percent – a 27 percent decrease from 2015 – according to the 21st edition of its annual Drug Trend Report.
Jan 04, 2017 11:43 am ET
Express Scripts Holding Company to Present at the J.P. Morgan Healthcare Conference
ST. LOUIS, Jan. 4, 2017 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) ("Express Scripts") announced today that it will present at the J.P. Morgan Healthcare Conference on Monday, January 9, 2017 at 11:30 a.m. Pacific Time (2:30 p.m. EST) at the Westin St. Francis in San Francisco, CA.
Dec 14, 2016 07:00 am ET
Express Scripts Holding Company Announces 2017 Financial Guidance
ST. LOUIS, Dec. 14, 2016 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) anticipates achieving adjusted earnings per diluted share1 for 2017 in the range of $6.82 to $7.02, representing growth of 7% to 10% from the midpoint of our 2016 adjusted EPS guidance range.
Dec 13, 2016 06:30 am ET
Lilly Announces Program to Provide Insulin at Discounted Prices
INDIANAPOLIS, Dec. 13, 2016 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that people who use Lilly insulin will be able to access discounted prices for their purchases starting January 1, 2017 via mobile and web platforms hosted by Blink Health. The discounts, provided by Lilly through a partnership with Express Scripts (NASDAQ: ESRX), may reduce costs for people who pay full retail prices at the pharmacy, such as those who have no insurance or are in the deductible phase of their high-deductible insurance plans.
Dec 12, 2016 07:00 am ET
Express Scripts Announces Enhancements to Industry Leading SafeGuardRx(SM) Programs
ST. LOUIS, Dec. 12, 2016 /PRNewswire/ -- As part of its ongoing mission to put medicine within reach, Express Scripts (NASDAQ: ESRX) today announced enhancements to its landmark SafeGuardRxSM programs focusing on hepatitis C and cancer.
Dec 05, 2016 08:32 am ET
Express Scripts Earns Top Marks in 2017 Corporate Equality Index
ST. LOUIS, Dec. 5, 2016 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) received a perfect score of 100 percent on the 2017 Corporate Equality Index (CEI), a national benchmarking survey and report on corporate policies and practices related to LGBT workplace equality, administered by the Human Rights Campaign Foundation. The company joins the ranks of 517 major U.S. businesses which also earned top marks this year.
Nov 14, 2016 02:36 pm ET
Express Scripts Holding Company Announces 2017 Financial Guidance Conference Call
ST. LOUIS, Nov. 14, 2016 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) today announced its intention to release its 2017 financial guidance on Wednesday, December 14, 2016, via press release before the market opens, followed by a conference call to discuss the 2017 financial guidance at 9:00 a.m. Eastern Time (8:00 a.m. Central Time) on Wednesday, December 14, 2016. The conference call will feature remarks by Tim Wentworth, CEO and President and Eric Slusser, CFO.
Nov 03, 2016 09:00 am ET
Express Scripts Puts Medicine Within Reach with 4-Star Medicare Prescription Drug Programs
ST. LOUIS, Nov. 3, 2016 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) today announced that Express Scripts Medicare® Prescription Drug Plan (PDP), contract S5660, has once again earned a 4-Star* quality rating from the Centers for Medicare and Medicaid Services (CMS).
Nov 01, 2016 01:15 pm ET
Express Scripts to Present at the Credit Suisse Healthcare Conference
ST. LOUIS, Nov. 1, 2016 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) (the "Company" or "Express Scripts") today announced that it will present at the Credit Suisse Annual Healthcare Conference on Tuesday, November 8, 2016 at 9:30 a.m. MST (11:30 a.m. EST) at The Phoenician in Scottsdale, AZ.
Oct 25, 2016 05:01 pm ET
Express Scripts Announces 2016 Third Quarter Results
ST. LOUIS, Oct. 25, 2016 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced 2016 third quarter net income of $722.9 million, or $1.15 per diluted share. 2016 third quarter adjusted earnings per diluted share, as detailed in Table 4, was $1.74.1
Oct 04, 2016 02:13 pm ET
Express Scripts Holding Company Announces Third Quarter Earnings Conference Call
ST. LOUIS, Oct. 04, 2016 (GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq:ESRX) announced today its intention to release its third quarter earnings on Tuesday, October 25, 2016 after the market closes and will hold its quarterly conference call to discuss third quarter results on Wednesday, October 26, 2016, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). ...
Sep 08, 2016 08:00 am ET
Express Scripts Launches Inflammatory Conditions Care Value Program(SM), Making America's Costliest Medication Class More Affordable
ST. LOUIS, Sept. 8, 2016 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) today launched its Inflammatory Conditions Care Value Program℠, a comprehensive approach to control costs and improve care for people with inflammatory conditions like rheumatoid arthritis, psoriasis and Crohn's Disease.
Sep 01, 2016 03:37 pm ET
Express Scripts Holding Company to Present at an Upcoming Conference
ST. LOUIS, Sept. 1, 2016 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) (the "Company" or "Express Scripts") announced today that it will present at the Morgan Stanley Global Healthcare Conference on Wednesday, September 14, 2016 at 1:00 p.m. Eastern Time (12:00 p.m. Central Time).
Aug 31, 2016 01:01 am ET
Express Scripts Launches Diabetes Care Value Program℠, Guaranteeing More Affordable, Higher-Quality Diabetes Care
ST. LOUIS, Aug. 31, 2016 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) today announced the launch of its Diabetes Care Value Program℠, the industry's most comprehensive approach to improve pharmacy care while controlling plan costs for people with diabetes.
Aug 25, 2016 01:51 pm ET
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Express Scripts Holding Company for Potential Breaches Of Fiduciary Duty By Its Board of Directors
NEW YORK, Aug. 25, 2016 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Express Scripts Holding Company (NASDAQ: ESRX).
Jul 28, 2016 10:15 am ET
Express Scripts Announces Final Results of Maximum Tender Offers
ST. LOUIS, Mo., July 28, 2016 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) (the "Company" or "Express Scripts") today announced the final tender results for its previously announced tender offers (the "Maximum Tender Offers") to purchase for cash up to an aggregate principal amount of the debt securities listed in the table below (collectively, the "Notes" and each a "series") that will not result in an aggregate amount that all holders of any such series of Notes are entitled to receive, excluding accrued and unpaid interest, for their Notes of such series that are validly
Jul 25, 2016 05:01 pm ET
Express Scripts Announces 2016 Second Quarter Results; Narrows 2016 Full-Year Adjusted Diluted EPS Guidance Range; Raises Mid-Point; Provides 2016 Third Quarter Guidance
ST. LOUIS, July 25, 2016 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced 2016 second quarter net income of $720.7 million, or $1.13 per diluted share. 2016 second quarter adjusted earnings per diluted share, as detailed in Table 4, was $1.57.1
Jul 14, 2016 07:15 pm ET
Express Scripts Announces Pricing of Maximum Tender Offers
ST. LOUIS, July 14, 2016 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) (the "Company" or "Express Scripts") today announced the consideration payable in connection with its previously announced tender offers (the "Maximum Tender Offers") to purchase for cash up to an aggregate principal amount of the debt securities listed in the table below (collectively, the "Notes" and each a "series") that will not result in an aggregate amount that all holders of any series of Notes are entitled to receive, excluding accrued and unpaid interest, for their Notes exceeding the applicable
Jul 14, 2016 09:00 am ET
Express Scripts Announces Early Tender Results and Upsizing of Maximum Tender Offers
ST. LOUIS, July 14, 2016 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) (the "Company" or "Express Scripts") today announced the early tender results for its previously announced tender offers (the "Maximum Tender Offers") to purchase for cash up to an aggregate principal amount of the debt securities listed in the table below (collectively, the "Notes" and each a "series") that will not result in an aggregate amount that all holders of any such series of Notes are entitled to receive, excluding accrued and unpaid interest, for their Notes of such series that are validly tend
Jul 11, 2016 05:34 pm ET
Express Scripts Holding Company Announces Second Quarter Earnings Conference Call
ST. LOUIS, July 11, 2016 (GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq:ESRX) announced today its intention to release its second quarter earnings on Monday, July 25, 2016 after the market closes and will hold its quarterly conference call to discuss second quarter results on Tuesday, July 26, 2016, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time)....
Jul 06, 2016 07:20 pm ET
Express Scripts Announces Pricing and Expiration of Any and All Tender Offer
ST. LOUIS, July 6, 2016 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) (the "Company" or "Express Scripts") today announced the pricing and expiration of its previously announced tender offer (the "Tender Offer") to purchase for cash any and all of its outstanding 2.650% senior notes due 2017 (the "Notes").
Jul 01, 2016 10:50 am ET
UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Investors in Express Scripts Holding Company of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 5, 2016 - ESRX
NEW YORK, July 1, 2016 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP:
Jun 29, 2016 09:58 am ET
Express Scripts Announces Tender Offers for Outstanding Debt Securities
ST. LOUIS, June 29, 2016 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) (the "Company" or "Express Scripts") today announced that it has commenced tender offers to purchase for cash the debt securities listed in the tables below (collectively, the "Securities" and each a "series").
Jun 28, 2016 04:54 pm ET
DEADLINE ALERT – EXPRESS SCRIPTS HOLDING COMPANY – Brower Piven Reminds Investors Of Upcoming Deadline And Encourages Shareholders Who Have Losses In Excess Of $100,000 To Contact The Firm – ESRX
STEVENSON, Md., June 28, 2016 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Express Scripts Holding Company (Nasdaq:ESRX) (“Express Scripts” or the “Company”) common stock during the period between February 24, 2015 to March 21, 2016, inclusive (the “Class Period”). Investors with losses in excess of $100,000 who wish to become proactively involved in the litigation have until Jul...
Jun 28, 2016 09:50 am ET
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Express Scripts Holding Company and a Lead Plaintiff Deadline of July 5, 2016 -- ESRX
NEW YORK, June 28, 2016 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Express Scripts Holding Company (NASDAQ:ESRX) securities between February 24, 2015 through March 21, 2016....
Jun 27, 2016 04:00 am ET
Hagens Berman Reminds Express Scripts Holding Company (NASDAQ: ESRX) Investors of July 5, 2016 Lead Plaintiff Deadline in Class Action Regarding Misrepresentions About Relationship With Largest Client
SAN FRANCISCO, June 27, 2016 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, reminds Express Scripts Holding Company (NASDAQ:ESRX) investors of the July 5, 2016 Lead Plaintiff deadline in the securities class action filed in the U.S. District Court for the Southern District of New York....
Jun 23, 2016 04:04 pm ET
STOCK ALERT: Rosen Law Firm Reminds Express Scripts Holding Company Investors of Important July 5 Deadline in Class Action - ESRX
NEW YORK, June 23, 2016 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Express Scripts Holding Company securities (NASDAQ:ESRX) from February 24, 2015 through March 21, 2016, both dates inclusive (the “Class Period”) of the important July 5, 2016 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Express Scripts investors under the federal securities laws....
Jun 17, 2016 11:07 pm ET
EXPRESS SCRIPTS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Ag
NEW ORLEANS, June 17, 2016 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 5, 2016 to file lead plaintiff applications in a securities class action lawsuit against Express Scripts Holding Company (NasdaqGS: ESRX), if they purchased the Company's securities between February 24, 2015 and March 21, 2016, inclusive (the "Class Period"). This action is pending in the United States District Court for the Southern District of New York.
Jun 15, 2016 04:23 pm ET
DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Express Scripts Holding Company (ESRX) and Lead Plaintiff Deadline July 5, 2016
NEW YORK, June 15, 2016 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed in the United States District Court, Southern District of New York on behalf of those who purchased shares of Express Scripts Holding Company ("Express Scripts" or the "Company") (NASDAQ: ESRX) between February 24, 2015 and March 21, 2016 inclusive (the "Class Period").
Jun 13, 2016 09:45 am ET
Lawsuit for Investors in shares of Express Scripts Holding Company (NASDAQ:ESRX) announced by Shareholders Foundation
SAN DIEGO, June 13, 2016 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit was filed in New York on behalf of certain purchasers of shares of Express Scripts Holding Company (NASDAQ:ESRX) over alleged Securities Laws Violations by Express Scripts Holding Company. Investors who purchased shares of Express Scripts Holding Company (NASDAQ:ESRX) have certain options and for certain investors there are short and strict deadlines running. Deadline: July 5, 2016. NASDAQ:ESRX investors should contact the Shareholders Foundation at [email protected] or cal...
Jun 10, 2016 01:38 pm ET
INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Express Scripts Holding Company and a Lead Plaintiff Deadline of July 5, 2016
NEW YORK, June 10, 2016 /PRNewswire/ -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Express Scripts Holding Company (NASDAQ: ESRX) securities between February 24, 2015 through March 21, 2016.
Jun 03, 2016 02:50 pm ET
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Express Scripts Holding Company - ESRX
NEW YORK, June 03, 2016 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Express Scripts Holding Company securities (NASDAQ:ESRX) from February 24, 2015 through March 21, 2016, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Express Scripts investors under the federal securities laws....
May 31, 2016 06:11 pm ET
Express Scripts Holding Company to Present at Upcoming Conferences
ST. LOUIS, May 31, 2016 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced that it will present at the following conferences:
May 29, 2016 12:40 pm ET
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Express Scripts Holding Company to Contact Brower Piven Before the Lead Plaintiff Deadline
STEVENSON, Md., May 29, 2016 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Express Scripts Holding Company (Nasdaq:ESRX) (“Express Scripts” or the “Company”) common stock during the period between February 24, 2015 to March 21, 2016, inclusive (the “Class Period”). Investors with losses in excess of $100,000 who wish to become proactively involved in the litigation have until July 5...
May 27, 2016 12:27 pm ET
INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Class Action Involving Express Scripts Holding Company and a Lead Plaintiff Deadline of July 5, 2016 -- ESRX
NEW YORK, May 27, 2016 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Express Scripts Holding Company (NASDAQ:ESRX) securities between February 24, 2015 through March 21, 2016....
May 25, 2016 09:25 am ET
Safirstein Metcalf LLP Reminds Investors of Upcoming Deadline to File Lead Plaintiff Papers in Express Scripts Holding Company Securities Case- ESRX
NEW YORK, May 25, 2016 (GLOBE NEWSWIRE) -- Safirstein Metcalf LLP announces that a class action has been filed in the U.S. District Court for the Southern District of New York on behalf of all those who purchased Express Scripts Holding Company (“Express Scripts” or the “Company”) (NASDAQ:ESRX) stock or options between February 24, 2015 and March 21, 2016 (the “Class Period”)....
May 25, 2016 08:30 am ET
EXPRESS SCRIPTS INVESTOR ALERT: Hagens Berman Reminds Express Scripts Holding Company (NASDAQ: ESRX) Investors of July 5th, 2016 Lead Plaintiff Deadline in Class Action Regarding Misrepresentions Abou
SAN FRANCISCO, May 25, 2016 (GLOBE NEWSWIRE) -- The following statement is being issued by Hagens Berman Sobol Shapiro LLP:...
May 23, 2016 03:29 pm ET
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Express Scripts Holding Company of Class Action Lawsuit and a Lead Plaintiff Deadline of July 5, 2016 - ESRX
NEW YORK, May 23, 2016 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:...
May 20, 2016 10:07 pm ET
EXPRESS SCRIPTS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Ag
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 5, 2016 to file lead plaintiff applications in a securities class action lawsuit against...
May 17, 2016 10:45 am ET
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Express Scripts Holding Company of Class Action Lawsuit and a Lead Plaintiff Deadline of July 5, 2016 -- ESRX
The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Express Scripts Holding Company ("Express Scripts" or the "Company") (NASDAQ: ESRX) between...
May 16, 2016 10:11 am ET
Law Offices of Marc S. Henzel Announces Investigation of Companies for Violations of the Federal Securities Laws
MERION, Pa., May 16, 2016 /PRNewswire/ -- The Law Offices of Marc S. Henzel (www.henzellaw.com), a firm focusing on shareholder litigation, gives notice to shareholders of investigation into the following securities for violations of the Federal Securities Laws:
May 12, 2016 07:00 pm ET
IMPORTANT EXPRESS SCRIPTS SHAREHOLDER ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a class action lawsuit has been commenced on behalf of shareholders of Express Scripts Hol
NEW YORK, May 12, 2016 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a class action lawsuit has filed in the United States District Court for the Southern District of New York on behalf of all those who purchased Express Scripts Holding Company (“Express Scripts” or the “Company”) (NASDAQ:ESRX) securities between February 24, 2015 and March 21, 2016 (the “Class Period”), inclusive....
May 10, 2016 05:30 pm ET
Safirstein Metcalf LLP Announces That a Class Action Lawsuit Has Been Filed Against Express Scripts Holding Company - ESRX
NEW YORK, May 10, 2016 (GLOBE NEWSWIRE) -- Safirstein Metcalf LLP announces that a class action has been filed in the U.S. District Court for the Southern District of New York on behalf of all those who purchased Express Scripts Holding Company (“Express Scripts” or the “Company”) (NASDAQ:ESRX) stock or options between February 24, 2015 and March 21, 2016 (the “Class Period”)....
May 10, 2016 12:53 pm ET
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Class Action Involving Express Scripts Holding Company and a Lead Plaintiff Deadline of July 5, 2016
NEW YORK, May 10, 2016 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Express Scripts Holding Company (NASDAQ:ESRX) securities between February 24, 2015 through March 21, 2016....
May 09, 2016 08:30 am ET
Hagens Berman Alerts Express Scripts Holding Company (NASDAQ: ESRX) Investors of Class Action for Failing to Disclose Material Known Risks and July 5, 2016 Lead Plaintiff Deadline
SAN FRANCISCO, May 09, 2016 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, alerts Express Scripts Holding Company (NASDAQ:ESRX) investors to the newly filed class action lawsuit and the July 5, 2016 lead plaintiff deadline....
May 07, 2016 04:00 am ET
Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Express Scripts Holding Company to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action La
STEVENSON, Md., May 07, 2016 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Express Scripts Holding Company (Nasdaq:ESRX) (Express Scripts or the “Company”) common stock during the period between February 24, 2015 to March 21, 2016, inclusive (the “Class Period”). Investors with losses in excess of $100,000 who wish to become proactively involved in the litigation have until July 5...
May 06, 2016 10:07 pm ET
EXPRESS SCRIPTS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Ag
NEW ORLEANS, La., May 06, 2016 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 5, 2016 to file lead plaintiff applications in a securities class action lawsuit against Express Scripts Holding Company (Nasdaq:ESRX), if they purchased the Company’s securities between February 24, 2015 and March 21, 2016, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York....
May 06, 2016 09:00 pm ET
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Express Scripts Holding Company (ESRX)
NEW YORK, May 06, 2016 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Express Scripts Holding Company (“Express Scripts” or the “Company”) (Nasdaq:ESRX) in the United States District Court for the Southern District of New York on behalf of purchasers of Express Scripts common stock between February 24, 2015 through March 21, 2016, inclusive (the “Class Period”), seeking to pursue remedies under the Securities Exchange Act of 1934 (the “Exchange Act”)....
May 06, 2016 08:45 pm ET
Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Express Scripts Holding Company
WAYNE, Pa., May 6, 2016 /PRNewswire/ -- Ryan & Maniskas, LLP announces that a class action lawsuit has been filed in United States District Court for the Southern District of New York on behalf of all persons or entities that purchased Express Scripts Holding Company ("Express Scripts" or the "Company") (NASDAQ: ESRX) securities between February 24, 2015 and March 21, 2016, inclusive (the "Class Period").
May 06, 2016 04:40 pm ET
Harwood Feffer LLP Announces Investigation of Express Scripts Holding Company
NEW YORK, May 6, 2016 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Express Scripts Holding Company ("Express Scripts" or the "Company") (NASDAQ: ESRX), concerning whether the board has breached its fiduciary duties to shareholders.
May 06, 2016 12:11 pm ET
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Express Scripts Holding Company of Class Action Lawsuit and a Lead Plaintiff Deadline of July 5, 2016 - ESRX
NEW YORK, May 06, 2016 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:...
May 05, 2016 05:00 pm ET
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Express Scripts Holding Company (ESRX)
NEW YORK, May 5, 2016 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Express Scripts Holding Company ("Express Scripts" or the "Company") (NASDAQ: ESRX). Such investors are advised to contact Peretz Bronstein or his investor relations analyst Yael Hurwitz at [email protected] or 212-697-6484.
May 05, 2016 04:00 pm ET
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Express Scripts Holding Company To Contact The Firm Before Lead Plaintiff Deadline -
NEW YORK, May 05, 2016 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Express Scripts Holding Company (“Express Scripts” or the “Company”) (Nasdaq:ESRX) of the July 5, 2016 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against the Company and certain officers....
May 05, 2016 02:46 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Express Script Holding Company - ESRX
NEW YORK, May 5, 2016 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Express Scripts Holding Company ("Express Scripts" or the "Company") (NASDAQ: ESRX). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 237.
May 05, 2016 02:18 pm ET
Bernstein Liebhard LLP Announces That A Suit Has Been Filed Against Express Scripts Holding Company
NEW YORK, May 5, 2016 /PRNewswire/ -- Bernstein Liebhard LLP today announced that a securities class action has been filed in the United States District Court for the Southern District of New York on behalf of a class (the "Class") consisting of all persons or entities who purchased or otherwise acquired the common stock of Express Scripts Holding Company ("Express Scripts" or the "Company") (NASDAQ: ESRX) between February 24, 2015 and March 21, 2016, inclusive (the "Class Period"). The complaint alleges that Defendants violated Sections 10(b) and 20(a) of the Securities Exchange Act of 193
May 05, 2016 11:25 am ET
Bernstein Litowitz Berger & Grossmann LLP Announces Securities Class Action Suit Filed Against Express Scripts Holding Company and Certain of Its Senior Executives
NEW YORK, May 5, 2016 /PRNewswire/ -- Bernstein Litowitz Berger & Grossmann LLP ("BLB&G") announces that on May 4, 2016, it filed a securities class action lawsuit on behalf of its client Melbourne Municipal Firefighters' Pension Trust Fund ("Melbourne") against Express Scripts Holding Company ("Express Scripts" or the "Company") (NASDAQ: ESRX), and certain of its senior executives (collectively "Defendants"). The action, which is captioned Melbourne Municipal Firefighters' Pension Trust Fund v. Express Scripts Holding Company, et al., No. 1:16-cv-03338 (S.D.N.Y.), asserts claims un
May 02, 2016 06:00 pm ET
Express Scripts Holding Company to Present at an Upcoming Conference
ST. LOUIS, May 2, 2016 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced that it will present at the Bank of America Merrill Lynch 2016 Health Care Conference on Wednesday, May 11, 2016 at 8:40 a.m. pacific (11:40 a.m. eastern).
Apr 25, 2016 05:08 pm ET
Express Scripts Announces 2016 First Quarter Results; Increases 2016 Guidance Range: Raises Mid-Point; Provides 2016 Second Quarter Guidance
ST. LOUIS, April 25, 2016 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced 2016 first quarter net income of $526.1 million, or $0.81 per diluted share. 2016 first quarter adjusted earnings per diluted share, as detailed in Table 4, was $1.22.1
Apr 05, 2016 09:00 am ET
U.S. Workers' Compensation Prescription Drug Spending Increased 2.2 Percent in 2015
ST. LOUIS, April 5, 2016 /PRNewswire/ -- Rising drug prices contributed to a 2.2 percent growth in pharmacy spending for American workers' compensation payers in 2015, according to a new report released today by Express Scripts (NASDAQ: ESRX).
Mar 14, 2016 09:00 pm ET
Increase in U.S. Drug Spending Slowed to 5.2 Percent in 2015 Through Cost-Saving Solutions, Specialized Care
ST. LOUIS, March 14, 2016 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) effectively held the 2015 growth rate in prescription drug spending to just 5.2 percent – roughly half the increase seen in 2014 ̶ through greater client adoption of its innovative solutions and specialized pharmacy care for patients, according to the 20th edition of its annual Drug Trend Report.
Mar 01, 2016 05:00 pm ET
Express Scripts Holding Company to Present at the Barclays Global Healthcare Conference
ST. LOUIS, March 1, 2016 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced that it will present at the Barclays Global Healthcare Conference on Tuesday, March 15, 2016 at 8:30 a.m. eastern at the Loews Miami Beach Hotel in Miami Beach, FL.
Feb 26, 2016 07:25 pm ET
Express Scripts Announces Pricing and Expiration of Tender Offer
ST. LOUIS, Feb. 26, 2016 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) (the "Company" or "Express Scripts") today announced the pricing and expiration of its previously announced tender offer (the "Tender Offer") to purchase for cash any and all outstanding 3.125% senior notes due 2016 listed in the table below (the "Notes").
Feb 25, 2016 08:05 pm ET
Express Scripts Announces Accelerated Share Repurchase Transaction
ST. LOUIS, Feb. 25, 2016 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) (the "Company or "Express Scripts") announced that it has entered into an accelerated share repurchase (ASR) agreement with Morgan Stanley & Co. LLC. Under the terms of the ASR agreement the Company will receive an aggregate initial delivery of approximately 32.1 million shares of the Company's common stock in exchange for a prepayment of $2.8 billion. The final number of shares to be repurchased will be based on the average of the daily volume-weighted average prices of the Company's common stock dur
Feb 22, 2016 08:50 am ET
Express Scripts Announces a Tender Offer for Any and All of the Outstanding 3.125% Senior Notes due 2016
ST. LOUIS, Feb. 22, 2016 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) (the "Company" or "Express Scripts") today announced that it has commenced a tender offer (the "Tender Offer") to purchase for cash any and all outstanding 3.125% senior notes due 2016 listed in the table below (the "Notes").
Feb 16, 2016 04:08 pm ET
Express Scripts Announces 2015 4th Quarter and Full Year Results; Narrows 2016 Guidance Range: Raises Mid-Point
ST. LOUIS, Feb. 16, 2016 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced 2015 fourth quarter and full year net income of $773.5 million and $2,476.4 million, respectively, or $1.13 and $3.56 per diluted share. 2015 fourth quarter and full year adjusted earnings per diluted share, as detailed in Table 4, was $1.56 and $5.53, respectively.1
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.